Around 1960: Clonidine, an α2-agonist, was developed as a nasal decongestant that worked by vasoconstriction.
Administered to a secretory she developed following features along with good nasal decongestant effect at low concentration
- Fell asleep for 24 h
- Low blood pressure
- Marked bradycardia
- Dryness of the mouth
1966: introduced in clinical practice reformulated for hypertension.
Source: Helmut Stähle,
A historical perspective: development of clonidine, Best Practice & Research Clinical Anaesthesiology, Volume 14, Issue 2, 2000, Pages 237-246, ISSN 1521-6896,
https://doi.org/10.1053/bean.2000.0079.
(http://www.sciencedirect.com/science/article/pii/S152168960090079X)
No comments:
Post a Comment